对于糖尿病患者的移动应用程序的评估:一个范围审查
1Department of Nursing, Daejeon University, Daejeon 34520, Republic of Korea.
Healthcare (Basel, Switzerland)
|February 10, 2024
概括
移动糖尿病管理应用程序提供了方便的用户体验,可以提高血糖水平. 建议在未来的应用程序开发中进行全面的可用性评估,并包括HbA1C和自我管理.
科学领域:
- 数字健康数字健康
- 糖尿病管理 糖尿病管理
- 移动卫生技术 移动卫生技术
背景情况:
- 对于糖尿病管理的移动医疗保健解决方案的兴趣越来越大.
- 关于移动糖尿病应用程序 (APP) 临床有效性的现有证据有限.
研究的目的:
- 进行范围审查,评估移动糖尿病管理应用程序的临床有效性.
- 综合这些应用程序的功能和可用性的发现.
主要方法:
- 使用以下术语进行系统搜索:"移动应用"",移动应用"和"糖尿病".
- 收录标准:英语,发表于2016年1月至2021年8月.
- 根据糖尿病类型 (第1类,第2类,两种) 和报告的应用功能 (功能,可用性) 分类研究.
主要成果:
- 确定的研究重点是1型 (2),2型 (6) 和两种 (4) 类型的糖尿病.
- 研究结果表明,移动糖尿病应用程序提供了方便的用户体验.
- 应用程序证明了在糖尿病患者中改善血糖水平的潜力.
结论:
- 强调使用ISO9241-11或MARS等标准进行全面的可用性评估,用于糖尿病应用程序开发.
- 建议将HbA1C和自我管理作为应用可行性的关键评估变量.
- 移动应用程序将成为患者主导糖尿病自我管理的重要工具.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
SBAR II: Application of SBAR
4.4K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.4K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201


